Pentoxifylline for bipolar depression: A pilot study

Affiliations

• ¹ Poul Hansen Depression Centre, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada; Department of Psychology, University of Windsor, Windsor, ON, Canada.
• ² Department of Psychiatry, Sunnybrook Health Science Center, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
• ³ Poul Hansen Depression Centre, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Brain and Cognition Discovery Foundation, Canada; University of Toronto, Toronto, ON, Canada.
• ⁴ Poul Hansen Depression Centre, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
• ⁵ Centre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, Toronto, ON, Canada.
• ⁶ Centre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, Toronto, ON, Canada; Sandra E Black Centre for Brain Resilience and Recovery, Department of Medical Biophysics, University of Toronto, ON, Canada.
• ⁷ Poul Hansen Depression Centre, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
• ⁸ Poul Hansen Depression Centre, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada. Electronic address: [email protected].